Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A

Haemophilia. 2014 Mar;20(2):e171-4. doi: 10.1111/hae.12342. Epub 2013 Dec 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Factor VIII / immunology*
  • Factor VIII / therapeutic use
  • Hemophilia A / drug therapy
  • Hemophilia A / immunology*
  • Humans
  • Isoantibodies / immunology*
  • Recombinant Proteins / immunology*
  • Recombinant Proteins / therapeutic use

Substances

  • Isoantibodies
  • Recombinant Proteins
  • Factor VIII